FDA label
What is calcium acetate used for?
The FDA-approved uses of calcium acetate, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD).”
Run it in Rivvi
Which 2027 plans near you dropped or restricted calcium acetate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Calcium Acetate, capsule
Indications and Usage, quoted from the label by Rising Pharma Holdings, Inc. (ANDA211038). Cross-references to other label sections are left out.
Calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD).
Source: DailyMed label, set id ce650ba5-fb42-e444-e053-2a95a90a075a, version 6, effective May 15, 2026. NDC 16571-813, one of 20 listings for this product.
Questions
What is calcium acetate used for?
The FDA label says: “Calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD).”
What drug class is calcium acetate?
FDA lists calcium acetate in the Blood Coagulation Factor and Phosphate Binder established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Calcium Acetate
- Is Calcium Acetate a controlled substance?Federal schedule
- Generic for PhosloFDA Orange Book
- Generic for Phoslo GelcapsFDA Orange Book
- Blood Coagulation Factors listFDA drug class
- Phosphate Binders listFDA drug class
- NDC 0054-0088Calcium Acetate NDC record
- NDC 0615-8632Calcium Acetate NDC record
- NDC 0904-7119Calcium Acetate NDC record